News
It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.
In 2021, Sly, biochemistry professor Harry Brumer, and a group of other researchers at the UBC developed GlycoCage, a ...
Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its ...
As a descendant of an Indigenous Amazonian tribe, Maria Astolfi was concerned about research she conducted as a graduate ...
The biotechnology company announced in December plans to invest $1 billion to build a second drug substance manufacturing plant in Holly Springs, North Carolina. Amgen also has manufacturing ...
Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...
Merck is investing $1 billion to build a U.S. plant in Delaware ... ingredients used in the making of such medicines. The drug maker on Tuesday announced a new 470,000-square-foot facility ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results